The view beyond venture capital: fundraising is an integral part of almost every young biotech's business strategy, yet many entrepreneurs do not have a systematic approach for identifying and prioritizing potential investors--many of whom work outside of traditional venture capital

Saved in:
Bibliographic Details
Published inNature biotechnology Vol. 32; no. 1; pp. 15 - 23
Main Authors Ford, Dennis, Nelsen, Barbara
Format Journal Article
LanguageEnglish
Published Nature Publishing Group 01.01.2014
Subjects
Biotechnology industry
Investments
Investor relations
Management
Venture capital
United States
Online AccessGet full text

Cover

More Information
ISSN:1087-0156
1546-1696